Quantifying, Visualizing, and Monitoring Lead Optimization

Journal of Medicinal Chemistry

Volumn 59, Issue 9, 2016, Pages 4189-4201

  Maynard, Andrew T ^a   Roberts, Christopher D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONITORING; PRECLINICAL STUDY; QUANTITATIVE STUDY; SAFETY; TELEMETRY; VITAL SIGN; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; HEPACIVIRUS; MEDICINAL CHEMISTRY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HEPACIVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 84969567634     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b00948     Document Type: Article

References (27)

1. Discussions and presentations, Cup XV, Santa Fe, NM, March 9-11, 2015 Openeye Scientific Software: Santa Fe, NM.
2. Paul, S. M.; Mytelka, D. S.; Dunwiddie, C.; Persinger, C.; Munos, B.; Lindborg, S.; Schacht, A. L. How to improve R&D productivity: the pharmaceutical industrys grand challenge Nat. Rev. Drug Discovery 2010, 9, 203-214 10.1038/nrd3078
3. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46, 3-26 10.1016/S0169-409X(00)00129-0
4. Meanwell, N. A. Improving Drug Candidates by Design: A Focus on Physiochemical Properties as a Means of Improving Compound Disposition and Safety Chem. Res. Toxicol. 2011, 24, 1420-1456 10.1021/tx200211v
5. Leeson, P. D.; Springthorpe, B. The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry Nat. Rev. Drug Discovery 2007, 6, 881-890 10.1038/nrd2445
6. Hopkins, A. L.; Keseru, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. The role of ligand efficiency metrics in drug discovery Nat. Rev. Drug Discovery 2014, 13, 105-121 10.1038/nrd4163
7. Meanwell, N. A.; Watkins, W. J. Introduction to Hepatitis C Virus (HCV) Therapies Special Thematic Issue J. Med. Chem. 2014, 57 (5) 1625-1626 10.1021/jm5000936
8. Shotwell, J. B.; Baskaran, S.; Chong, P.; Creech, K. L.; Crosby, R. M.; Dickson, H.; Fang, J.; Garrido, D.; Mathis, A.; Maung, J.; Parks, D. J.; Pouliot, J. J.; Price, D. J.; Rai, R.; Seal, J. W.; Schmitz, U.; Tai, V. W. F.; Thomson, M.; Xie, M.; Xiong, Z. Z.; Peat, A. J. Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization ACS Med. Chem. Lett. 2012, 3, 565-569 10.1021/ml300090x
9. Miller, J. F.; Chong, P.; Shotwell, J. B.; Catalano, J.; Tai, V.; Fang, J.; Banka, A.; Roberts, C.; Youngman, M.; Zhang, H.; Xiong, Z.; Mathis, A.; Pouliot, J.; Hamatake, R.; Price, D.; Seal, J.; Stroup, L.; Creech, K.; Carballo, L.; Todd, D.; Spaltenstein, A.; Furst, S.; Hong, Z.; Peat, A. J. Hepatitis C Replication Inhibitors That Target the Viral NS4B Protein J. Med. Chem. 2014, 57, 2107-2120 10.1021/jm400125h
10. Kazmierski, W. M.; Maynard, A.; Duan, M.; Baskaran, S.; Botyanszki, J.; Crosby, R.; Dickerson, S.; Tallant, M.; Grimes, R.; Hamatake, R.; Leivers, M.; Roberts, C.; Walker, J. Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound J. Med. Chem. 2014, 57, 2058-2073 10.1021/jm4013104
11. Walker, J.; Crosby, R.; Wang, A.; Woldu, E.; Vamathevan, J.; You, S.; Voitenleitner, C.; Remlinger, K.; Duan, M.; Kazmierski, W.; Hamatake, R. Preclinical characterization of GSK2336805, a novel inhibitor of Hepatitis C virus replication that selects for resistance in NS5A Antimicrob. Agents Chemother. 2014, 58, 38-47 10.1128/AAC.01363-13
12. Maynard, A.; Crosby, R. M.; Ellis, B.; Hamatake, R.; Hong, Z.; Johns, B. A.; Kahler, K. M.; Koble, C.; Leivers, A.; Leivers, M. R.; Mathis, A.; Peat, A. J.; Pouliot, J. J.; Roberts, C. D.; Samano, V.; Schmidt, R. M.; Smith, G. K.; Spaltenstein, A.; Stewart, E. L.; Thommes, P.; Turner, E. M.; Voitenleitner, C.; Walker, J. T.; Waitt, G.; Weatherhead, J.; Weaver, K.; Williams, S.; Wright, L.; Xiong, Z. Z.; Haigh, D.; Shotwell, J. B. Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase J. Med. Chem. 2014, 57, 1902-1913 10.1021/jm400317w
13. A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects; ClinicalTrials.gov: Bethesda, MD, 2013; NCT01879462, https://clinicaltrials.gov/ct2/show/NCT01879462.
14. Leivers, A. L.; Tallant, M.; Shotwell, J.; Dickerson, S.; Leivers, M.; McDonald, O.; Gobel, J.; Creech, K.; Strum, S.; Mathis, A.; Rogers, S.; Moore, C.; Botyanszki, J. J. Med. Chem. 2014, 57, 2091-2106 10.1021/jm400781h
15. Hoaglin, D. C.; Mosteller, F.; Tukey, J. W. Understanding Robust and Exploratory Data Analysis; John Wiley & Sons: New York, 1983; pp 404-427.
16. Harrington, J. The desirability function Ind. Qual. Control 1965, 21, 494-498
17. Derringer, G.; Suich, R. Simultaneous optimization of several response variables J. Qual. Technol. 1980, 12, 214-219
18. Mandal, A.; Johnson, K.; Wu, C. F. J.; Bornemeier, D. Identifying Promising Compounds in Drug Discovery: Genetic Algorithms and Some New Statistical Techniques J. Chem. Inf. Model. 2007, 47, 981-988 10.1021/ci600556v
19. Nissink, J. W. M.; Degorce, S. Analyzing compound and project progress through multi-objective-based compound quality assessment Future Med. Chem. 2013, 5, 753-767 10.4155/fmc.13.45
20. Peterson, J. J. A posterior predictive approach to multiple response surface optimization J. Qual. Technol. 2004, 36, 139-153
21. Lee, M.; Kim, K. Expected Desirability Function: Consideration of Both Location and Dispersion Effects in Desirability Function Approach Qual. Technol. Quant. Manage. 2007, 4, 365-377
22. Ribardo, C.; Allen, T. T. An Alternative Desirability Function for Achieving Six Sigma Quality Qual. Reliab. Engng. Int. 2003, 19, 227-240 10.1002/qre.523
23. Alter, M. J. Epidemiology of hepatitis C virus infection World J. Gastroenterol. 2007, 13, 2436-2441 10.3748/wjg.v13.i17.2436
24. Shannon, C. E. Prediction of Entropy and Printed English Bell Syst. Tech. J. 1951, 30, 50-64 10.1002/j.1538-7305.1951.tb01366.x
25. ChemAxon, Molecular Descriptor Generator 5.9.1; generatemd -k CF.
26. The concepts and methodologies of this study were subsequently developed into a web based LO telemetry dashboard in conjunction with McLaren Applied Technologies.
27. Silver, N. The Signal and the Noise: Why So Many Predictions Fail - But Some Dont; Penguin Press: New York, 2012; pp 1-73.